Further evidence supporting a role for metabolic plasticity during melanoma progression and metastasis comes from a study investigating the role of peroxisome proliferator-activated receptor γ coactivator α (PGC1α), a master regulator of mitochondrial function [16]. This evidence concerns the gene PPARGC1A and melanoma.